Skip to main content

Charles Lynch

Head of Investor Relations

Pediatrix Medical Group, Inc. (MD)

Equibles does not estimate personal net worth.

Get an email with a short summary when Pediatrix Medical Group, Inc. publishes a filing, an earnings call transcript or a press release.

Get MD alerts

About Charles Lynch

Charles Lynch is recorded as Head of Investor Relations at Pediatrix Medical Group, Inc. (MD). Earlier roles on record: Board Member at Glen Burnie Bancorp (GLBZ) until December 31, 2023. Glen Burnie Bancorp reported in an 8-K filed January 4, 2024 that Charles Lynch resigned as member of the Board of Directors of Glen Burnie Bancorp, effective December 31, 2023. Charles Lynch has spoken on 4 earnings calls across 1 company, most recently for Pediatrix Medical Group, Inc. on August 6, 2024. Pediatrix Medical Group, Inc. is classified in the Medical Care Facilities industry within the Healthcare sector. Other leadership on record at Pediatrix Medical Group, Inc. includes James D. Swift, M.D. (CEO, COO and Board Member), Mark S. Ordan (CEO and Chairman), Guy P. Sansone (Chairman and Board Member) and 7 others.

“On December 31, 2023, Chares Lynch, Jr., a member of the Board of Directors of Glen Burnie Bancorp since 2003, resigned from the Board for personal reasons, effective December 31, 2023.”
Glen Burnie Bancorp Form 8-K, filed January 4, 2024 · Read the filing

Charles Lynch on recent calls

“I'm going to quickly read our forward-looking statements before we begin the call. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.”
CEO, Pediatrix Medical Group, Inc. Q2 FY2024 Earnings Call ·
“I'll quickly read through our forward-looking statements, and then we'll get into our content. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.”
CEO, Pediatrix Medical Group, Inc. Q1 FY2024 Earnings Call ·
“I quickly read our forward-looking statements and then turn the call over to Mark. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.”
Head of Investor Relations, Pediatrix Medical Group, Inc. Q3 FY2020 Earnings Call ·
“Thank you, operator, and good morning, everyone, and welcome to our first quarter earnings conference call. I'll read our forward-looking statements. And with us today are also Roger Medel and Stephen Farber.”
CEO, Pediatrix Medical Group, Inc. Q1 FY2020 Earnings Call ·

Affiliation history

Company network

Leadership on record at Pediatrix Medical Group, Inc.

Recent activity